Literature DB >> 24340836

Association of the M3151 variant in the transient receptor potential vanilloid receptor-1 (TRPV1) gene with type 1 diabetes in an Ashkenazi Jewish population.

Menachem Sadeh1, Benjamin Glazer2, Zohar Landau3, Julio Wainstein4, Tall Bezaleli5, Ron Dabby1, Aaron Hanukoglu3, Mona Boaz6, Esther Leshinsky-Silver5.   

Abstract

BACKGROUND: Type 1 diabetes in humans is an autoimmune disease in which Tcells target pancreatic islets of Langerhans, leading to the progressive destruction of the insulin-producing beta cells. Both genetic and environmental factors contribute to the development of autoimmune diabetes. The non-obese diabetic (NOD) mouse model of human type 1 diabetes demonstrates two missense mutations in the transient receptor potentialvanilloid receptor-1 (TRPVi) gene.
OBJECTIVES: To investigate whether polymorphism in the TRPV1 gene may play a role in the predisposition to human type 1 diabetes.
METHODS: We genotyped 146 Ashkenazi Jewish type 1 diabetic patients and 205 Ashkenazi Jewish healthy controls for the rs222747 (M3151), rs224534 (T4691) and rs8065080 (1585V) variants of the TRPV1 gene.
RESULTS: There was a significant increase in the rs222747 (M3151) variant of the TRPV1 gene in the type 1 diabetes cohort compared to the control: rs222747 (M3151) homozygous: (61% vs. 48.3%, P = 0.02). Logistic regression analysis revealed that type 1 diabetes was significantly associated with rs222747 (M3151), such that having diabetes increased the odds of rs222747 homozygosity (M3151) by 67.2%, odds ratio 1.6, 95% confidence interval 1.08-2.57, P < 0.02. No difference was found in the rs224534 (T4691) and rs8065080 (1585V) allelic variants. There was no difference in any of the TRPV1 variants by gender, age when type 1 diabetes was diagnosed, body mass index, glycemic control, blood pressure, positive autoantibodies (ICA, GAD, IAA), and other autoimmune diseases.
CONCLUSIONS: Our study demonstrates that TRPV1 may be a susceptible gene for type 1 diabetes in an Ashkenazi Jewish population. These results should be replicated in the same ethnic group and in other ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24340836

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  5 in total

1.  Antidiabetic Effect of Rehmanniae Radix Based on Regulation of TRPV1 and SCD1.

Authors:  Ye Liu; Ruizheng Zhu; Bei Liu; Wuqing Wang; Ping Yang; Zhonglian Cao; Xiaolei Yang; Wandi Du; Qing Yang; Jingru Liang; Jiarong Hu; Guo Ma
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

2.  Agonist-dependence of functional properties for common nonsynonymous variants of human transient receptor potential vanilloid 1.

Authors:  Sen Wang; John Joseph; Luda Diatchenko; Jin Y Ro; Man-Kyo Chung
Journal:  Pain       Date:  2016-07       Impact factor: 7.926

3.  Neurovascular microcirculatory vasodilation mediated by C-fibers and Transient receptor potential vanilloid-type-1 channels (TRPV 1) is impaired in type 1 diabetes.

Authors:  P Marche; S Dubois; P Abraham; E Parot-Schinkel; L Gascoin; A Humeau-Heurtier; P H Ducluzeau; G Mahe
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

Review 4.  Molecular Regulations and Functions of the Transient Receptor Potential Channels of the Islets of Langerhans and Insulinoma Cells.

Authors:  Md Shahidul Islam
Journal:  Cells       Date:  2020-03-11       Impact factor: 6.600

5.  KCC2 rs2297201 Gene Polymorphism Might be a Predictive Genetic Marker of Febrile Seizures.

Authors:  Sanja Dimitrijevic; Biljana Jekic; Suzana Cvjeticanin; Aleksandra Tucovic; Tamara Filipovic; Ivana Novaković; Bojana Ivić; Dimitrije Nikolic
Journal:  ASN Neuro       Date:  2022 Jan-Dec       Impact factor: 5.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.